222 related articles for article (PubMed ID: 32886822)
1. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
2. Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study.
Min YW; Kang D; Shin JY; Kang M; Park JK; Lee KH; Lee JK; Lee KT; Rhee PL; Kim JJ; Guallar E; Cho J; Lee H
Aliment Pharmacol Ther; 2019 Oct; 50(7):760-768. PubMed ID: 31448440
[TBL] [Abstract][Full Text] [Related]
3. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
[TBL] [Abstract][Full Text] [Related]
4. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor Use Increases Pyogenic Liver Abscess Risk: A Nationwide Cohort Study.
Oh JH; Kang D; Kang W; Guallar E; Cho J; Min YW
J Neurogastroenterol Motil; 2021 Oct; 27(4):555-564. PubMed ID: 34642276
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
7. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
9. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2017; 12(12):e0189114. PubMed ID: 29216279
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors.
Baek YH; Kang EJ; Hong S; Park S; Kim JH; Shin JY
Int J Cancer; 2022 Apr; 150(8):1291-1300. PubMed ID: 34877670
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Front Immunol; 2021; 12():736036. PubMed ID: 34659225
[TBL] [Abstract][Full Text] [Related]
14. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
[TBL] [Abstract][Full Text] [Related]
15. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease.
Choden T; Zhang H; Sakuraba A
Ann Med; 2023 Dec; 55(1):2198775. PubMed ID: 37070427
[TBL] [Abstract][Full Text] [Related]
16. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
19. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
[TBL] [Abstract][Full Text] [Related]
20. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
